Cargando…
Complement-dependent cytotoxicity of anti-human osteogenic sarcoma monoclonal antibodies.
Two mouse monoclonal antibodies against the human osteogenic sarcoma 791T were examined for their capacity to exert complement-dependent cytotoxicity against a panel of human tumour cell lines. Cytotoxicity was most evident against the immunizing tumour 791T although significant reactivity was direc...
Autores principales: | Price, M. R., Pimm, M. V., Baldwin, R. W. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1982
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2011198/ https://www.ncbi.nlm.nih.gov/pubmed/6958308 |
Ejemplares similares
-
Antigenicity and drug susceptibility of human osteogenic sarcoma cells "escaping" a cytotoxic methotrexate-albumin-monoclonal antibody conjugate.
por: Embleton, M. J., et al.
Publicado: (1984) -
Antitumour reactions of monoclonal antibody against a human osteogenic-sarcoma cell line.
por: Embleton, M. J., et al.
Publicado: (1981) -
A bispecific monoclonal antibody against methotrexate and a human tumour associated antigen augments cytotoxicity of methotrexate-carrier conjugate.
por: Pimm, M. V., et al.
Publicado: (1990) -
Immunolocalization of the murine monoclonal antibody, 791T/36 within primary human colorectal carcinomas and identification of the target antigen.
por: Price, M. R., et al.
Publicado: (1984) -
Recombinant ricin toxin A chain cytotoxicity against carcinoembryonic antigen expressing tumour cells mediated by a bispecific monoclonal antibody and its potentiation by ricin toxin B chain.
por: Embleton, M. J., et al.
Publicado: (1991)